PPA
IBIO icon

Parametric Portfolio Associates’s iBio IBIO Stock Holding History

Parametric Portfolio Associates’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-36
Closed -$37K – 4009
2020
Q3 		$37K Buy
+36
New +$52.2K ﹤0.01% 3886

Other funds holding IBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Parametric Portfolio Associates's IBIO Position: Q4 2020 in Review

Parametric Portfolio Associates sold out of iBio (IBIO) in Q4 2020, closing a stake of 36 shares — an estimated $37K sold.

Parametric Portfolio Associates first reported a position in IBIO in Q3 2020 and held it in 1 quarter. The position peaked at $37K in Q3 2020. 89 funds tracked by Wall St. Rank hold IBIO as of Q4 2020.

  • Parametric Portfolio Associates reported no remaining iBio position as of Q4 2020 after selling out during the quarter.
  • Parametric Portfolio Associates sold 36 iBio shares in Q4 2020, an estimated $37K.
  • Parametric Portfolio Associates first reported a position in iBio in Q3 2020 and held it in 1 quarter.
  • Parametric Portfolio Associates's iBio position peaked at $37K in Q3 2020.
  • 89 funds tracked by Wall St. Rank held iBio as of Q4 2020.

Based on Parametric Portfolio Associates's 13F filing for Q4 2020, filed 12 Feb 2021.